ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,185 | +28.2% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $4,045 | -57.2% | 500 | -16.7% | 0.00% | – |
| Q4 2022 | $9,450 | +5.0% | 600 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | 0.0% | 600 | -3.8% | 0.00% | – |
| Q2 2022 | $9,000 | -18.2% | 624 | +4.0% | 0.00% | – |
| Q1 2022 | $11,000 | +450.0% | 600 | +500.0% | 0.00% | – |
| Q2 2021 | $2,000 | -93.3% | 100 | -91.7% | 0.00% | -100.0% |
| Q1 2021 | $30,000 | +200.0% | 1,200 | -25.0% | 0.00% | 0.0% |
| Q4 2020 | $10,000 | 0.0% | 1,600 | -58.4% | 0.00% | 0.0% |
| Q3 2020 | $10,000 | +66.7% | 3,850 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +50.0% | 3,850 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -42.9% | 3,850 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $7,000 | +40.0% | 3,850 | -9.4% | 0.00% | – |
| Q3 2019 | $5,000 | -44.4% | 4,250 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $9,000 | -50.0% | 4,250 | +41.7% | 0.00% | -50.0% |
| Q1 2019 | $18,000 | -41.9% | 3,000 | -29.4% | 0.00% | -50.0% |
| Q4 2018 | $31,000 | -26.2% | 4,250 | +46.0% | 0.00% | -20.0% |
| Q3 2018 | $42,000 | – | 2,910 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |